{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:01:41Z","timestamp":1783702901081,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Inflammatory bowel diseases (IBDs) are chronic conditions of the digestive tract, often requiring life-long treatments in order to achieve and maintain remission. However, treatment adherence among patients with IBD can frequently be suboptimal, which can compromise disease control and long-term outcomes. The aim of this study was to analyze the adherence rate and to identify factors that significantly influence treatment adherence in patients with IBD. Materials and Methods: The study employed a cross-sectional design and was conducted at the Fundeni Clinical Institute, a tertiary medical center in Bucharest, Romania. The treatment adherence was assessed using the Medication Adherence Report Scale-5 (MARS-5), with patients scoring greater than 23 considered adherent. Anxiety, depression and perceived stress were assessed using the Depression, Anxiety and Stress Scale-21 (DASS-21). Perceived social support was measured with the Multidimensional Scale of Perceived Social Support (MSPSS), and coping strategies were assessed using the Brief Coping Orientation to Problems Experienced Inventory (Brief COPE Inventory). Results: A total of 188 patients were included in the final analysis. Of these, 99 patients (52.7%) were male and 109 (58.0%) had a diagnosis of Crohn\u2019s disease. The majority of patients (81.9%) were receiving treatment with advanced therapies, including biologics or small molecules. Forty patients were receiving their therapy through more than one route of administration. Optimal adherence was noted in 160 patients (85.1%). Patients treated with advanced therapies (biologics and small molecules) had significantly higher odds of optimal adherence (OR 10.52, 95% CI: 4.3\u201325.74, p &lt; 0.001), with a rate of adherence of 92.2%. Significantly lower odds of adherence were found for the oral (OR 0.35, 95% CI: 0.14\u20130.83, p = 0.01) and rectal (OR 0.09, 95% CI: 0.03\u20130.29, p &lt; 0.001) routes of administration, while the intravenous administration had higher odds of adherence (OR 4.85, 95% CI: 1.02\u201322.9, p = 0.04) compared to the subcutaneous route. Other factors associated with an improved adherence were being retired (OR 3.5, 95% CI: 1.13\u201310.8, p = 0.029) and using positive reframing (p = 0.04), planning (p = 0.01) and venting (p = 0.02) as coping strategies; active smoking (OR 0.26, 95% CI: 0.11\u20130.6, p = 0.002), active disease (OR 0.36, 95% CI: 0.16\u20130.81, p = 0.014) and behavioral disengagement (p = 0.04) were associated with impaired treatment adherence. No significant differences in adherence were observed between disease phenotypes. Conclusions: The route of administration, smoking status and psychosocial factors, such as perceived stress of social support and coping strategies, may play an important role in influencing treatment adherence in patients with IBD. While the disease phenotype was not associated with differences in adherence, patients with active disease had significantly lower odds of optimal adherence.<\/jats:p>","DOI":"10.3390\/medicina61091512","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:09:32Z","timestamp":1756080572000},"page":"1512","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment Adherence in Inflammatory Bowel Disease: The Role of Demographic, Clinical, and Psychosocial Factors"],"prefix":"10.3390","volume":"61","author":[{"given":"Tudor Gheorghe","family":"Stroie","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-0786","authenticated-orcid":false,"given":"Liliana Veronica","family":"Diaconescu","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Preda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Diculescu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora Mihaela","family":"Chirea","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Istratescu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Meianu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucsandra","family":"Diculescu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmin","family":"Ciora","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5348-0341","authenticated-orcid":false,"given":"Cristian George","family":"Tieranu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Gastroenterology, Elias Emergency Hospital, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4112-083X","authenticated-orcid":false,"given":"Ovidiu","family":"Popa-Velea","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.mib.0000179467.01748.99","article-title":"Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: Psychometric assessments and a comparison with general population norms","volume":"11","author":"Bernklev","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2468-1253(19)30358-9","article-title":"Global burden of inflammatory bowel disease","volume":"5","author":"Jairath","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.dld.2013.07.005","article-title":"Clinical implications of mucosal healing in the man-agement of patients with inflammatory bowel disease","volume":"45","author":"Orlando","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.dld.2025.04.032","article-title":"Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus","volume":"57","author":"Armuzzi","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5217\/ir.2017.15.4.434","article-title":"Medication adherence in inflammatory bowel disease","volume":"15","author":"Chan","year":"2017","journal-title":"Intest. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ibd\/izz253","article-title":"Risk Factors for Medication Nonadherence to Self-Injectable Bio-logic Therapy in Adult Patients with Inflammatory Bowel Disease","volume":"26","author":"Shah","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","unstructured":"(2025, July 06). Adherence to Long-Term Therapies: Evidence for Action. Available online: https:\/\/iris.who.int\/handle\/10665\/42682."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ajg.2009.685","article-title":"Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review","volume":"105","author":"Jackson","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","first-page":"101915","article-title":"Shared decision-making improves adherence to mesalamine in ulcerative colitis: A prospective, multicenter, non-interventional cohort study in Germany","volume":"31","author":"Kruis","year":"2025","journal-title":"World J. Gastroen-Terol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ibd\/izaa056","article-title":"Utility of the MARS-5 in Assessing Medication Adherence in IBD","volume":"27","author":"Stone","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","article-title":"The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories","volume":"33","author":"Lovibond","year":"1995","journal-title":"Behav. Res. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1207\/s15327752jpa5503&4_17","article-title":"Psychometric characteristics of the Multidimensional Scale of Per-ceived Social Support","volume":"55","author":"Zimet","year":"1990","journal-title":"J. Pers. Assess."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1207\/s15327558ijbm0401_6","article-title":"You want to measure coping but your protocol\u2019s too long: Consider the brief COPE","volume":"4","author":"Carver","year":"1997","journal-title":"Int. J. Behav. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/MIB.0b013e31828132cb","article-title":"Adherence to anti-TNF therapy in inflammatory bowel diseases: A systematic review","volume":"19","author":"Lopez","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/ibd\/izy102","article-title":"Nonadherence to Biologic Therapies in Inflammatory Bowel Disease","volume":"24","author":"Wentworth","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gastrohep.2021.04.011","article-title":"Adherence to subcutaneous biologic treatment for inflammatory bowel disease","volume":"45","author":"Ramos","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/MIB.0000000000000562","article-title":"Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis","volume":"21","author":"Boyle","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(02)01383-9","article-title":"Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis","volume":"114","author":"Kane","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/14740338.2011.583915","article-title":"Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease","volume":"10","author":"Selinger","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2036.2003.01648.x","article-title":"Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease","volume":"18","author":"Shale","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Belei, O., Basaca, D.G., Olariu, L., Pantea, M., Bozgan, D., Nanu, A., S\u00eerbu, I., M\u0103rginean, O., and En\u0103tescu, I. (2024). The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051361"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rada, C., Gheonea, D., \u0162ieranu, C.G., and Popa, D.E. (2022). Diagnosis and Psychotherapeutic Needs by Early Maladaptive Schemas in Patients with Inflammatory Bowel Disease. Front. Psychol., 12.","DOI":"10.3389\/fpsyg.2021.807107"},{"key":"ref_25","first-page":"2493","article-title":"Psychosocial profile of the patients with inflammatory bowel disease","volume":"20","author":"Ilias","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"King, K., Czuber-Dochan, W., Chalder, T., and Norton, C. (2025). Medication Non-Adherence in Inflammatory Bowel Disease: A Systematic Review Identifying Risk Factors and Opportunities for Intervention. Pharmacy, 13.","DOI":"10.3390\/pharmacy13010021"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Popa, S.L., Fadgyas Stanculete, M., Grad, S., Brata, V.D., Duse, T.A., Badulescu, A.V., Dragan, R.V., Bottalico, P., Pop, C., and Ismaiel, A. (2024). Coping Strategies and Inflammatory Bowel Disease: A Narrative Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061630"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"G\u00eelc-Blanariu, G.E., \u0218tefnescu, G., Trifan, A.V., Moscalu, M., Dimofte, M.G., \u0218tefnescu, C., Drug, V.L., Afrsnie, V.A., and Ciocoiu, M. (2020). Sleep Impairment and Psychological Distress among Patients with Inflammatory Bowel Disease-beyond the Obvious. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072304"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/0022-3514.56.2.267","article-title":"Assessing coping strategies: A theoretically based approach","volume":"56","author":"Carver","year":"1989","journal-title":"J. Pers. Soc. Psychol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/0278-6133.23.2.207","article-title":"Social support and patient adherence to medical treatment: A meta-analysis","volume":"23","author":"DiMatteo","year":"2004","journal-title":"Health Psychol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1512\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:33Z","timestamp":1760034873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091512"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091512","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]}}}